Sagar Lonial, MD, FACP

Sagar Lonial, MD, FACP, is professor and chair, Department of Hematology and Medical Oncology, and chief medical officer, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. He completed his medical degree at the University of Louisville School of Medicine in Kentucky. He completed his internship and residency at Baylor College of Medicine in Houston, TX, served as chief medical resident at the Ben Taub General Hospital and the Texas Heart Institute at St. Luke’s Hospital, and completed a fellowship in hematology/oncology at Emory University School of Medicine.

Board certified in hematology and medical oncology, Dr Lonial is internationally recognized as a leading authority in multiple myeloma treatment and research. Dr Lonial’s research focuses on combination therapy in B-cell malignancies focusing on multiple myeloma. He is a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and multiple myeloma. His clinical interests include evaluating the combination of new molecular-targeted agents for B-cell cancers and methods to enhance immunity following allogeneic or autologous stem cell transplantation.

Dr Lonial’s recent research has focused on combinations of novel agents as therapy for multiple myeloma and lymphoma, and, particularly, on evaluating combinations that may result in the synergistic inhibition of the PI3K/AKT pathway. His lab has recently received funding from the Multiple Myeloma Research Foundation, the Lymphoma Research Foundation, and the Leukemia & Lymphoma Society. Dr Lonial has authored more than 200 peer-reviewed publications and abstracts. He serves on the editorial boards of the American Journal of Clinical Oncology, the Journal of Clinical Oncology, and Leukemia; is the myeloma editor for Clinical Lymphoma, Myeloma, & Leukemia; and is the hematologic malignancies section editor for Cancer. In addition, he is an invited or ad hoc reviewer for several publications, including Blood, Haematologica, the Journal of Clinical Oncology, Clinical Cancer Research, Leukemia, The New England Journal of Medicine, and others. He has given a number of local, national, and international presentations. 

Dr Lonial is a member of several local committees and committees for the American Society of Hematology. He is involved in numerous professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the American Society for Blood and Marrow Transplantation. He is vice-chair of the Myeloma Committee in the Eastern Cooperative Oncology Group and chair of the Steering Committee for the Multiple Myeloma Research Consortium. Additionally, he is on the International Myeloma Society Board of Directors and the International Myeloma Foundation Scientific Advisory Board. He is also a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.